Roche Diagnostics GmbH, part of Roche Holding AG, is a company headquartered in Mannheim, Germany, involved in laboratory analytical instruments. Andreas Schmitz and Claus Haberda are the current co-CEOs of the firm. On January 01, 1999 Roche Holding AG acquired Roche Diagnostics GmbH.

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Roche Diagnostics Operations, Inc. provides healthcare services. It offers commercial physical and biological research and development. The company is headquartered in Indianapolis, IN.

Kunming Institute of Zoology (KIZ) (中国科学院昆明动物研究所), one of the 20 biological institutes under the Chinese Academy of Sciences (CAS), is one of China's first class zoological research institutes, located in Kunming, Yunnan province. The Institute has access to the unique and diversified animal resources of the Eastern Himalayas as well as a wide variety of the species from across Southeast Asia, the southern parts of Yunnan province being part of the Indo-Burma biodiversity hotspot. KIZ focuses on life science research, with research groups including systematic zoology, conservation biology, cytology, molecular biology, genome evolution, reproductive and developmental biology, neurobiology, immunological biology on important virus disease, zoological toxicology and primate biology.

Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. It operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China, and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan.

NewScen Coast Bio Pharmaceutical Co. Ltd. is a joint venture company headquartered in Tianjin City, China, that manufactures and distributes in-vitro diagnostic devices.

Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts is a teaching hospital of Harvard Medical School. It was formed out of the 1996 merger of Beth Israel Hospital (founded in 1916) and New England Deaconess Hospital (founded in 1896). Among independent teaching hospitals, Beth Israel Deaconess Medical Center consistently ranks in the top three recipients of biomedical research funding from the National Institutes of Health. Research funding totals nearly $200 million annually. BIDMC researchers run more than 850 active sponsored projects and 200 clinical trials. The Harvard-Thorndike General Clinical Research Center, the oldest clinical research laboratory in the United States, has been located on this site since 1973.

Lightdeck Diagnostics engages in the development of clinical diagnostics and sample testing products. It offers the LightDeck platform, which consists of portable fluorescence analyzer and disposable, multiplex test cartridges. Its products are used in the medical, veterinary, environmental, food, agricultural, and military market segments. The company was founded by Christopher J. Myatt, Michael J. Lockhead, and Sarah C. Hatcher in 2009 and is headquartered in Boulder, CO.

Vitaleech Bioscience NV develops a recom­bi­nant enzyme for the treatment of periodontitis. It offers medicines for the prevention or treatment of periodontitis, a common form of inflammation of the gum tissue that may result in the loss of teeth. The company was founded in 1999 and is headquartered in Bergen op Zoom, the Netherlands.

Institut Pasteur Korea Research Foundation provides research and development for the treatment of infectious and chronic diseases. It develops a technology-based approach to therapeutic development through cellular models, high content screening and medicinal chemistry. The company was founded on December 29, 2003 and is headquartered in Seongnam, South Korea.

Part of Johnson & Johnson, SEQUUS Pharmaceuticals, Inc. is a company headquartered in Menlo Park, CA. The firm markets lipid-based biopharmaceutical products mainly to treat cancer and infectious diseases. It was acquired by ALZA Corp., a subsidiary of Johnson & Johnson since June 2001, on March 16, 1999 for $658.03 million.

Immunex Corporation develops, manufactures, and markets therapeutic products for the treatment of cancer, infectious diseases, and autoimmune disorders. It offers products, such as Enbrel that is used in the treatment of rheumatoid arthritis; Novantrone, which is used to treat acute nonlymphocytic leukemia and pain associated with prostate cancer; and Leukine for use in bone marrow transplant patients. The company has franchise operations. It has a strategic alliance with American Home Products. The company was founded in 1981 and is based in Seattle, Washington. As of July 15, 2002, Immunex Corporation was acquired by Amgen, Inc.

Shenzhen New Industries Biomedical Engineering Co., Ltd. principally engages in the research, development, production, and sale of automatic chemiluminescence immunoassay instruments and supporting reagents. The company was founded on December 15, 1995 and is headquartered in Shenzhen, China.

The Institute Pasteur is a private, non-profit foundation. Its mission is to help prevent and treat diseases, mainly those of infectious origin, through research, teaching, and public health initiatives.The Institut Pasteur is a research center of international renown ideally located in the very heart of Paris. Each year the institute hosts a multitude of scientific and medical conferences and meetings as well as events on a variety of themes.

Wuhan Kangdeqing Biotechnology Co., Ltd., established on 2010-08-06, Business scope includes biomedical technology,Research and development of medical technology,Technology transfer and service consulting;medical electronic equipment,Office automation equipment,Research and development of instrument equipment and consumable software,Sales,Maintenance repair and consulting services;II,IIIclass of medical devices:6820General diagnostic equipment;6821Medical electronic equipment;6823Medical Ultrasonic Instruments and Related Equipment;6826Physiotherapy and Rehabilitation Equipment;6827Chinese medicine equipment;6840Clinical Laboratory Analytical Instruments(Contains in vitro diagnostic reagents);6841Medical testing and basic equipment;6854operating room,emergency room,Consulting room equipment and appliances;6856Ward Nursing Equipment and Appliances;6857Disinfection and sterilization equipment and utensils;6858medical cold therapy,low temperature,Refrigeration equipment and appliances;6863Dental materials;6864Medical hygiene materials and dressings;6870Wholesale of software;Intelligent automatic flusher,Research and Development of Disinfectants,Production,Sales;II,IIIclass of medical devices,Production of in vitro diagnostic reagents,Sales;Health Management Services;Health Management Consulting(Does not include diagnosis and treatment);Import and export(Does not contain goods or technologies that are prohibited or restricted from import and export by the state);Labor protection supplies,Production of daily necessities,Sales.(Projects subject to approval by law,Business activities can only be carried out after approval by relevant departments)(Involved in licensing projects,It should be operated after obtaining the permission of the relevant department)

Dongguan Pengzhi Biotechnology Co., Ltd., established on 2016-08-22, Business scope includes biological products,R&D of medical devices,Production,Sales and technology transfer,Technical Services;Sales:Chemical Products(Free of Hazardous Chemicals);Import and export,Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)